SARS-CoV-2 infection in patients with multiple myeloma: survey in 23 centers across Europe and USA

Dytfeld D., Radocha J., Hajek R., CENGİZ SEVAL G., Berkac M., Coriu D., ...More

Acta Haematologica Polonica, vol.54, no.2, pp.82-85, 2023 (Scopus) identifier

  • Publication Type: Article / Article
  • Volume: 54 Issue: 2
  • Publication Date: 2023
  • Doi Number: 10.5603/ahp.a2023.0016
  • Journal Name: Acta Haematologica Polonica
  • Journal Indexes: Scopus, BIOSIS, Central & Eastern European Academic Source (CEEAS), EMBASE
  • Page Numbers: pp.82-85
  • Keywords: COVID-19, myeloma
  • Ankara University Affiliated: Yes

Abstract

Introduction: Despite several studies, the impact of coronavirus disease 2019 on patients with multiple myeloma remains uncertain. Material and methods: We performed a survey that covered the period of the first and second waves of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in 23 centers inseven countries. Out of 352 patients with myeloma and SARS-CoV-2, 23% died. Results/Conclusions: Logistic regression showed a lower risk of death among patients treated with proteasome inhibitor and a higher risk of death for those who had a severe or a very severe course of disease.